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Severe infections with Histoplasma capsulatum are commonly observed in patient 
with secondary immunodeficiency disorders. We report a two and a half years old boy 
previously healthy with disseminated cutaneous histoplasmosis. Using whole exome 
sequencing, we found an indel mutation at the CD40LG gene, suggesting a diagnosis 
of hyper-IgM (HIGM) syndrome, even in the absence of the usual features for the dis-
ease. Interestingly, the patient lives in a region endemic for histoplasmosis. The unusual 
infections in our case suggest that in children with severe histoplasmosis and resident in 
endemic areas, HIGM syndrome should be considered as a diagnosis.
Keywords: CD40LG, hyper-IgM syndrome, histoplasmosis, whole exome sequencing, primary immunodeficiency 
diseases
INtRoDUCtIoN
We report a two and a half years old boy from a rural tropical region of Ecuador, who presented 
with a 6-month history of neck and scalp skin lesions. These papules gradually evolved to become 
pustular and then xerotic, erythematous-ulcerations (Figures 1A,B). Lesional biopsy was consistent 
with cutaneous histoplasmosis (Figure 1C). We initially ruled out secondary immunodeficiencies, 
including HIV, raising the suspicion of a primary immunodeficiency disease (PIDD).
During the course of his evaluation, our patient was also identified as having mucous-containing 
diarrhea positive for Cryptosporidium parvum, a pulmonary infection with tracheal aspirates yield-
ing Pseudomonas aeruginosa and Candida albicans, as well as oral lesions consistent with candidiasis. 
He additionally had hepatomegaly 3 cm below the costal margin and diffuse lymphadenopathy.
Laboratory studies demonstrated normal white blood cell counts and lymphocyte subpopula-
tions (CD3+: 2,410  cells/μL, CD3+CD4+: 1,501  cells/μL, CD3+CD8+: 845  cells/μL, and CD19+: 
682 cells/μL). Serum immunoglobulin levels were as follows: IgG, 251 mg/dL (480–1200 mg/dL); 
IgA, below detectable limits (33–180 mg/dL); and IgM, 51 mg/dL (54–200 mg/dL).
FIGURe 1 | (a,B) Disseminated vesicular or dry erythematous and ulcerous lesions over the body and scalp of the proband. (C) Histological analysis of the dermis 
showed intense edema, necrosis of the dermal fibers, and pseudo-granulomatous tissue. A few giant cells and a polymorphonuclear infiltrate are observed. 
Macrophages are present, loaded with oval-shaped parasites, between 2 and 4 µm in size, positive for periodic acid–Schiff staining (intense red-violet), consistent 
with Histoplasma capsulatum. (D) Pedigree of the family sequenced in this study. The arrow indicates the proband. The maternal uncles died of unspecified 
infections before they reached two years of age. The lower panel shows the Sanger sequencing results and familial segregation for the mutation in CD40LG in the 
affected proband and both unaffected parents. The mutation is inherited from the mother. (e) Normal CD4 and CD8 percentages and ratio within the CD3+ 
population. (F) Complete absence of CD40L upregulation in patient CD3+ population when stimulated for 6 h with SEB as compared to healthy paternal sample.
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taBLe 1 | Variant information. The dinucleotide substitution is predicted 
by conceptual translation to result in a PTC at position 78. The bioinformatics 
prediction suggests a likely disease causing mutation associated with HIGM1.
Gene name CD40LG CD40LG
Chromosome chrX chrX
Position (hg19) 135732501 135732502
Sequence: reference/alternative C/A C/A
Proband: reference/alternative 4/160 4/168
Mother: reference/alternative 163/126 162/125
Father: reference/alternative 147/0 143/0
Mutation type Indel
Refseq NM_000074
Mutation: cDNA c.233_234delinsAA
Mutation: protein p.Ser78*
Predicted effect Premature truncating codon (PTC), 
disease causing
Associated phenotype/MIM number Immunodeficiency with hyper-IgM, type 
1; HIGM1/308230
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Amphotericin B, 1 mg/kg/day was provided for 4 weeks, and 
intravenous immunoglobulin (600  mg/kg) was administered. 
After a 2-month hospitalization, the patient was discharged with 
a prophylactic therapy regimen consisting of trimethoprim/sul-
famethoxazole (80/400 mg) every 3 days, itraconazole (100 mg) 
daily for 2 months and then every 3 days for an additional year, 
and IVIG 400  mg/kg every 6  weeks. For the past 2  years, the 
patient has been free of infection with an approximate IgG trough 
level between 409 and 560 mg/dL.
The patient is the only son of unrelated and healthy parents. 
Family history was notable for two maternal uncles who died 
in childhood from pneumonia and diarrhea—suggesting an 
X-linked recessive trait for susceptibility to severe infections.
The patient’s infections, altered laboratory values and both 
personal and familial history, suggested a PIDD, probably an 
X-linked combined immunodeficiency. Given the lack of tools to 
further investigate the immunology of our patient at our center 
in Ecuador, as well as the relatively broad differential diagnosis 
surrounding combined immunodeficiency and Histoplasma 
susceptibility, we performed whole exome sequencing (WES) as 
a family trio (patient, mother, and father) as part of an ongoing 
collaboration with the Baylor-Hopkins Center for Mendelian 
Genomics (1). Exome capture was performed with the in-house 
developed BCM-HGSC Core design (52 Mb; Roche NimbleGen, 
Madison, WI, USA), as previously described (2). The variant 
calling was performed by the ATLAS2 suite (3), identifying 
a consecutive dinucleotide substitution at the exon 2 of the 
CD40LG in the proband (Table 1), as the most probable variant 
associated with our patient’s phenotype. This mutation creates 
a premature stop codon (NM_000074:exon2:c.233_234delinsA
A:p.S78*), predicted to result in the loss of the entire extracellular 
portion of the protein (including the TNF-like domain required 
for the interaction with CD40) or a complete loss-of-function 
allele due to mRNA instability and nonsense-mediated decay 
as predicted by our algorithm. This variant was not reported at 
ExAC database at the time of the publication and was confirmed 
by Sanger sequencing in the family trio (Figure  1D). The 
mother was a healthy carrier, and the variant thus segregated 
with the family history. Other gene variant information from the 
WES data of the affected individual is listed in Table 1. While 
this variant would represent a novel mutation, it suggests the 
diagnosis of hyper-IgM (HIGM) syndrome, and it is consistent 
with several reported nonsense or frameshift mutations in early 
codons associated with CD40LG deficiency (4). Induced expres-
sion of CD40L after staphylococcal enterotoxin B superantigen 
stimulation was examined, and complete lack of expression of 
the protein by the CD4+ T cells of the patient was observed 
(Figures 1E,F).
BaCKGRoUND aND DIsCUssIoN
Hyper-IgM is a well-known PIDD caused by defects in class-switch 
recombination and/or B cell costimulation. It commonly presents 
with Pneumocystis jirovecii pneumonia and Cryptosporidium 
parvum diarrhea or more standard consequences of hypogam-
maglobulinemia (4). Our patient presented with diarrhea and 
pneumonia, and we confirmed the presence of Cryptosporidium 
parvum in the feces. Susceptibility to the microorganism isolated 
from the tracheal aspirate, P. aeruginosa and Candida albicans, 
while not common in HIGM, has been previously reported (5, 6). 
Interestingly, our patient presented with a low serum IgM level, 
and although the disease name suggests high levels of IgM, in at 
least 50% of cases of CD40LG deficiency, the IgM level can be 
normal or even low (7).
The main presentation in our patient was the histoplasmosis, 
although uncommon in HIGM, it has been previously reported. 
Interestingly, these cases have been reported in areas considered 
endemic for histoplasmosis (8): the American cases near to the 
Mississippi River Valley (9, 10) and the Latin-American in Brazil 
and Argentina (5, 11). Additional factors such as bird contact, 
presence of guano soil, or farming activities inside the endemic 
areas seem to be important (8). Remarkably, our patient family 
lives in an isolated rural region in the north of Ecuador with 
exclusive dedication to farming. Since Histoplasma infections 
even inside endemic areas are commonly observed in patients 
with risk factors like HIV or old males after years of smoking 
(8); in children without risk factors and severe histoplasmosis, 
who live in endemic areas, HIGM may represent a more likely 
presentation for this diagnosis. Also while lymphadenopathy in 
HIGM is rare, our patient was likely to have this as a manifesta-
tion of the histoplasmosis. Unfortunately, it was not possible to 
biopsy the lymph nodes or the liver and thus we were not able to 
confirm this. Nevertheless, it has been previously reported that 
in endemic areas, children with histoplasmosis could develop 
the infection in the peripheral lymph nodes (12), suggesting 
again that environmental influences are essential, and thus the 
need to think about PIDD from a geographical region-specific 
perspective.
CoNCLUDING ReMaRKs
We present detailed clinical findings in a patient with X-linked 
HIGM due to a novel indel mutation in CD40LG, for whom the 
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diagnosis was confirmed after WES was performed. The unu-
sual infections in our case suggest that in children with severe 
histoplasmosis, resident in endemic areas, HIGM should be 
considered as a diagnosis.
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